0001171843-18-001229.txt : 20180220 0001171843-18-001229.hdr.sgml : 20180220 20180220081545 ACCESSION NUMBER: 0001171843-18-001229 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180216 FILED AS OF DATE: 20180220 DATE AS OF CHANGE: 20180220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOYES TIMOTHY P CENTRAL INDEX KEY: 0001185035 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 18623132 MAIL ADDRESS: STREET 1: 1365 MAIN STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 formfour.xml FORM 4 X0306 4 2018-02-16 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001185035 NOYES TIMOTHY P C/O PROTEON THERAPEUTICS 200 WEST STREET WALTHAM MA 02451 1 1 0 0 President and CEO Common Stock 2018-02-16 4 D 0 2997 2.11 D 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017. The selling price of $2.11 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.10 to $2.15. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ George A. Eldridge as attorney-in-fact for Timothy P. Noyes 2018-02-20